FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to otorhinolaryngology. It can be used for correction of olfactory disorder in pathology of nose and paranasal sinuses. Method consists in carrying out training of olfactory function with application of device for diagnostics and rehabilitation of olfactory disorders "ReviSmell" and application of 15 test aromas, which are used as essential oils: muscatel, pine, peony, eucalyptus, cloves, chamomile, mint, coffee, cinnamon, lavender, bergamot, lemon, balm, valerian, wormwood. Before the beginning of the treatment, the sense of smell is assessed by supplying 15 test aromas to the nasal mask on the above device using a scenario – diagnostics with patient immersion into virtual reality using virtual reality glasses. When determining more than 13 test aromas and their correct identification with a visual analogue and response time ≤ 5 seconds, normosmia is established. If none of 15 test aromas are recognized, anosmia is diagnosed, in other cases – hyposmia. If the patient reports an unpleasant smell of the test aroma, parosmia is diagnosed. If observing the olfactory disorder, the correction is carried out on the ReviSmell apparatus using the rehabilitation scenario. In the course of correction, 15 test aromas are used, wherein the sequence and time of supply of aromas depends on the previous assessment of smell. During the first two weeks of treatment, 15 test aromas are used, the first to select are those aromas that the patient correctly recognized, assessed as pleasant, and the response time was equal to ≤ 5 seconds during diagnostics. Then one uses aromas which the patient misidentified but rated as pleasant, and the response time is ≤ 5 seconds. Further, it is proposed to recognize aromas that the patient identified correctly, assessed as pleasant, but response time ≥ 5 seconds. Finally, the patient is offered aromas which he incorrectly identified and referred to as unpleasant. Correction of olfactory disorder is considered to be effective if the patient is able to identify more than 13 test aromas, and the response time is equal to ≤ 5 seconds. Duration of correction ranges from 14 days to 1, 3 and 6 months depending on patient’s ability to identify test aromas and response time spent on identification.
EFFECT: method is easy to use, improves patient’s quality of life.
3 cl, 4 dwg, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
USING METHOD FOR PREPARING CONDITIONED MEDIUM HAVING REGENERATIVE POTENTIAL FOR INTRANASAL ADMINISTRATION IN TREATING CHRONIC POST-VIRAL OLFACTORY DISORDERS | 2023 |
|
RU2816357C1 |
METHOD FOR REHABILITATION OF PATIENTS WITH OLFACTORY DISORDERS | 2022 |
|
RU2806234C1 |
METHOD FOR ASSESSING THE THRESHOLD OF OLFACTION IN CHILDREN | 2021 |
|
RU2770290C1 |
METHOD FOR PHYSICAL THERAPY OF ANOSMIA AFTER CORONAVIRUS INFECTION | 2021 |
|
RU2751823C1 |
DEVICE FOR DIAGNOSTICS AND REHABILITATION OF OLFACTORY DISORDERS WITH POSSIBILITY OF COMPUTER CONTROL AND INTEGRATION WITH BIOFEEDBACK SYSTEM | 2021 |
|
RU2791921C2 |
METHOD OF TREATING PATIENTS WITH OLFACTORY DYSFUNCTION IN ATROPHIC RHINITIS | 2019 |
|
RU2713786C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR PARKINSONIAN DISEASE AND ESSENTIAL TREMOR | 2011 |
|
RU2467697C1 |
METHOD OF DIFFERENTIAL DIAGNOSIS OF PARKINSON'S DISEASE AND ESSENTIAL TREMOR | 2022 |
|
RU2800309C1 |
METHOD FOR TREATING DYSOSMIA CAUSED BY CORONAVIRUS INFECTION | 2021 |
|
RU2791808C2 |
USE OF PEPTIDE OF FORMULA MET-GLU-HIS-PHE-PRO-GLY-PRO FOR TREATING ANOSMIA IN COVID-19 | 2023 |
|
RU2816583C1 |
Authors
Dates
2024-11-19—Published
2024-05-24—Filed